ESC Premium Access

Cystatin C predicts cardiovascular events in patients with coronary artery disease both among patients with and among those without type 2 diabetes

Congress Presentation

About the speakers

Doctor Alexander Vonbank

VIVIT Institute, Feldkirch (Austria)
0 follower

Doctor Arthur Mader

VIVIT Institute, Feldkirch (Austria)
3 presentations
0 follower

5 more presentations in this session

Serum amyloid A-low-density-lipoprotein complex and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX Study

Speaker: Doctor M. Suzuki (Wako, Saitama, JP)

Thumbnail

Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in general population: evidence from nhanes 1999-2010

Speaker: Doctor Z. Qiu (Beijing, CN)

Thumbnail

Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention

Speaker: Mrs J. Li (Beijing, CN)

Thumbnail

A direct comparison of non-invasive blood markers of liver fibrosis as associates of cardiovascular risk. The Athens cardiometabolic registry

Speaker: Doctor S. Athanasopoulos (GR)

Thumbnail

Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications

Speaker: Doctor J. Liu (Oxford, GB)

Thumbnail

Access the full session

Novel biomarkers for cardiovascular risk prediction

Speakers: Doctor A. Vonbank, Doctor A. Mader, Doctor M. Suzuki, Doctor Z. Qiu, Mrs J. Li...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations